Dr. Mitchell S Cairo, MD
Claim this profileNew York Medical College
Expert in Lymphoma
Studies Leukemia
25 reported clinical trials
37 drugs studied
About Mitchell S Cairo, MD
Education:
- Completed undergraduate studies at the University of Wisconsin.
- Earned an M.D. from the University of California, San Francisco.
- Completed a Pediatrics Residency at the University of California, San Francisco.
- Undertook a Pediatric Hematology/Oncology Fellowship at Indiana University.
Experience:
- Vice Chair of the Department of Pediatrics at New York Medical College.
- Professor of Pediatrics, Medicine, Pathology, Microbiology & Immunology, and Cell Biology & Anatomy.
- Chief of Pediatric Hematology, Oncology, and Stem Cell Transplantation at Westchester Medical Center.
- Director of the Children and Adolescent Cancer and Blood Diseases Center.
Area of expertise
1Lymphoma
Global LeaderStage IV
Stage III
Stage II
2Leukemia
Stage III
Stage II
CD33
Affiliated Hospitals
Clinical Trials Mitchell S Cairo, MD is currently running
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
Targeted Immunotherapy
for Leukemia
A Phase I trial to determine the safety of targeted immunotherapy with daratumumab (DARA) IV after total body irradiation (TBI)-based myeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT) for children, adolescents, and young adults (CAYA) with high risk T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LLy). Pre- and post-HCT NGS-MRD studies will be correlated with outcomes in children, adolescents, and young adults with T-ALL undergoing allogeneic HCT and post-HCT DARA treatment. The study will also evaluate T-cell repertoire and immune reconstitution prior to and following DARA post-HCT treatment and correlate with patient outcomes.
Recruiting2 awards Phase 17 criteria
More about Mitchell S Cairo, MD
Clinical Trial Related2 years of experience running clinical trials · Led 25 trials as a Principal Investigator · 17 Active Clinical TrialsTreatments Mitchell S Cairo, MD has experience with
- Defibrotide
- Gemtuzumab Ozogamicin
- Brentuximab Vedotin
- Ifosfamide
- Etoposide
- BK CTL
Breakdown of trials Mitchell S Cairo, MD has run
Lymphoma
Leukemia
Myeloid Leukemia
Acute Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mitchell S Cairo, MD specialize in?
Mitchell S Cairo, MD focuses on Lymphoma and Leukemia. In particular, much of their work with Lymphoma has involved Stage IV patients, or patients who are Stage III.
Is Mitchell S Cairo, MD currently recruiting for clinical trials?
Yes, Mitchell S Cairo, MD is currently recruiting for 15 clinical trials in Valhalla New York. If you're interested in participating, you should apply.
Are there any treatments that Mitchell S Cairo, MD has studied deeply?
Yes, Mitchell S Cairo, MD has studied treatments such as Defibrotide, Gemtuzumab Ozogamicin, Brentuximab Vedotin.
What is the best way to schedule an appointment with Mitchell S Cairo, MD?
Apply for one of the trials that Mitchell S Cairo, MD is conducting.
What is the office address of Mitchell S Cairo, MD?
The office of Mitchell S Cairo, MD is located at: New York Medical College, Valhalla, New York 10595 United States. This is the address for their practice at the New York Medical College.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.